Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.
Open Access
- 1 March 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 134 (3) , 1609-1618
- https://doi.org/10.4049/jimmunol.134.3.1609
Abstract
Four monoclonal IgG antibodies to purified, recombinant murine gamma-interferon (rIFN-gamma) have been produced by fusion of immune hamster splenocytes with HAT-sensitive murine myeloma cells. Specificity was confirmed either with an enzyme-linked immunosorbent assay (ELISA) that used immobilized rIFN-gamma or with a radioimmunoassay that employed soluble 125I-rIFN-gamma and heat-killed, fixed Staphylococcus aureus-bearing Protein A. Competition binding experiments suggested that the monoclonal antibodies (MoAb) displayed two distinct epitope specificities: one displayed by H1 and H2, and the other displayed by H21 and H22. By using murine-human recombinant IFN-gamma hybrid molecules, the H1/H2 epitope was shown to depend on the amino-terminus of IFN-gamma, whereas the H21/H22 epitope was formed by the carboxy-terminal amino acid sequence. The MoAb also reacted with natural IFN-gamma. When bound to a surface, all four MoAb, but not normal hamster IgG, removed 100% of the antiviral and MAF activities present in supernatants of cultures of the murine 24/G1 T cell hybridoma. In free solution, all four antibodies inhibited IFN-gamma dependent antiviral activity, but with different efficiencies. Soluble H21/H22 also blocked all of the 24/G1-derived activity that induces nonspecific tumoricidal activity in macrophages (MAF) while H1/H2 enhanced MAF activity. The differential inhibitory or enhancing activities of H21 or H1 reflected their ability to inhibit or enhance binding of 125I-rIFN-gamma to macrophages, respectively. Soluble H21/H22 and solid-phase H1/H2 inhibited 100% of the MAF, microbicidal, and Ia-inducing activities from lymphokine preparations produced by mitogen stimulation of normal murine splenic cells. These results help to establish definitive structure-function relationships for the IFN-gamma molecule, and indicate that IFN-gamma is the primary lymphokine responsible for inducing nonspecific tumoricidal activity and Ia antigen expression, and for enhancing microbicidal activity in macrophages.This publication has 22 references indexed in Scilit:
- Plasmid-directed synthesis of hepatitis B surface antigen in monkey cells.Molecular and Cellular Biology, 1983
- Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.The Journal of Immunology, 1982
- Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity.The Journal of Experimental Medicine, 1982
- Identification of a T cell hybridoma that produces large quantities of macrophage-activating factor.The Journal of Experimental Medicine, 1982
- Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.The Journal of Immunology, 1982
- Correction of defective macrophage differentiation in C3H/HeJ mice by an interferon-like molecule.The Journal of Immunology, 1982
- Partial purification and chemical characterization of macrophage cytotoxicity factor (MCF, MAF) and its separation from migration inhibitory factor (MIF).The Journal of Immunology, 1981
- Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.The Journal of Immunology, 1981
- SV40-transformed simian cells support the replication of early SV40 mutantsCell, 1981
- Characterization of the Effects of Endotoxin on Macrophage Tumor Cell KillingThe Journal of Immunology, 1978